This report contains market size and forecasts of Neuroscience Antibodies and Assays in Global, including the following market information:
Global Neuroscience Antibodies and Assays Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Neuroscience Antibodies and Assays market was valued at 2485.3 million in 2020 and is projected to reach US$ 3084.8 million by 2027, at a CAGR of 5.6% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuroscience Antibodies and Assays companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuroscience Antibodies and Assays Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Neuroscience Antibodies and Assays Market Segment Percentages, By Type, 2020 (%)
Consumables
Instruments
China Neuroscience Antibodies and Assays Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Neuroscience Antibodies and Assays Market Segment Percentages, By Application, 2020 (%)
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Centers
Global Neuroscience Antibodies and Assays Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Neuroscience Antibodies and Assays Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Neuroscience Antibodies and Assays Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Neuroscience Antibodies and Assays Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Thermo Fisher
Abcam
Bio-Rad
Merck
Cell Signaling Technology
Genscript
Rockland Immunochemicals
BioLegend
Santa Cruz Biotechnology
Roche
Siemens
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Neuroscience Antibodies and Assays Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuroscience Antibodies and Assays Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuroscience Antibodies and Assays Overall Market Size
2.1 Global Neuroscience Antibodies and Assays Market Size: 2021 VS 2027
2.2 Global Neuroscience Antibodies and Assays Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuroscience Antibodies and Assays Players in Global Market
3.2 Top Global Neuroscience Antibodies and Assays Companies Ranked by Revenue
3.3 Global Neuroscience Antibodies and Assays Revenue by Companies
3.4 Top 3 and Top 5 Neuroscience Antibodies and Assays Companies in Global Market, by Revenue in 2020
3.5 Global Companies Neuroscience Antibodies and Assays Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuroscience Antibodies and Assays Players in Global Market
3.6.1 List of Global Tier 1 Neuroscience Antibodies and Assays Companies
3.6.2 List of Global Tier 2 and Tier 3 Neuroscience Antibodies and Assays Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neuroscience Antibodies and Assays Market Size Markets, 2021 & 2027
4.1.2 Consumables
4.1.3 Instruments
4.2 By Type - Global Neuroscience Antibodies and Assays Revenue & Forecasts
4.2.1 By Type - Global Neuroscience Antibodies and Assays Revenue, 2016-2021
4.2.2 By Type - Global Neuroscience Antibodies and Assays Revenue, 2022-2027
4.2.3 By Type - Global Neuroscience Antibodies and Assays Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neuroscience Antibodies and Assays Market Size, 2021 & 2027
5.1.2 Pharmaceutical & Biotechnology Companies
5.1.3 Academic & Research Institutes
5.1.4 Hospitals & Diagnostic Centers
5.2 By Application - Global Neuroscience Antibodies and Assays Revenue & Forecasts
5.2.1 By Application - Global Neuroscience Antibodies and Assays Revenue, 2016-2021
5.2.2 By Application - Global Neuroscience Antibodies and Assays Revenue, 2022-2027
5.2.3 By Application - Global Neuroscience Antibodies and Assays Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Neuroscience Antibodies and Assays Market Size, 2021 & 2027
6.2 By Region - Global Neuroscience Antibodies and Assays Revenue & Forecasts
6.2.1 By Region - Global Neuroscience Antibodies and Assays Revenue, 2016-2021
6.2.2 By Region - Global Neuroscience Antibodies and Assays Revenue, 2022-2027
6.2.3 By Region - Global Neuroscience Antibodies and Assays Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Neuroscience Antibodies and Assays Revenue, 2016-2027
6.3.2 US Neuroscience Antibodies and Assays Market Size, 2016-2027
6.3.3 Canada Neuroscience Antibodies and Assays Market Size, 2016-2027
6.3.4 Mexico Neuroscience Antibodies and Assays Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Neuroscience Antibodies and Assays Revenue, 2016-2027
6.4.2 Germany Neuroscience Antibodies and Assays Market Size, 2016-2027
6.4.3 France Neuroscience Antibodies and Assays Market Size, 2016-2027
6.4.4 U.K. Neuroscience Antibodies and Assays Market Size, 2016-2027
6.4.5 Italy Neuroscience Antibodies and Assays Market Size, 2016-2027
6.4.6 Russia Neuroscience Antibodies and Assays Market Size, 2016-2027
6.4.7 Nordic Countries Neuroscience Antibodies and Assays Market Size, 2016-2027
6.4.8 Benelux Neuroscience Antibodies and Assays Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Neuroscience Antibodies and Assays Revenue, 2016-2027
6.5.2 China Neuroscience Antibodies and Assays Market Size, 2016-2027
6.5.3 Japan Neuroscience Antibodies and Assays Market Size, 2016-2027
6.5.4 South Korea Neuroscience Antibodies and Assays Market Size, 2016-2027
6.5.5 Southeast Asia Neuroscience Antibodies and Assays Market Size, 2016-2027
6.5.6 India Neuroscience Antibodies and Assays Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Neuroscience Antibodies and Assays Revenue, 2016-2027
6.6.2 Brazil Neuroscience Antibodies and Assays Market Size, 2016-2027
6.6.3 Argentina Neuroscience Antibodies and Assays Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neuroscience Antibodies and Assays Revenue, 2016-2027
6.7.2 Turkey Neuroscience Antibodies and Assays Market Size, 2016-2027
6.7.3 Israel Neuroscience Antibodies and Assays Market Size, 2016-2027
6.7.4 Saudi Arabia Neuroscience Antibodies and Assays Market Size, 2016-2027
6.7.5 UAE Neuroscience Antibodies and Assays Market Size, 2016-2027
7 Players Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Corporate Summary
7.1.2 Thermo Fisher Business Overview
7.1.3 Thermo Fisher Neuroscience Antibodies and Assays Major Product Offerings
7.1.4 Thermo Fisher Neuroscience Antibodies and Assays Revenue in Global (2016-2021)
7.1.5 Thermo Fisher Key News
7.2 Abcam
7.2.1 Abcam Corporate Summary
7.2.2 Abcam Business Overview
7.2.3 Abcam Neuroscience Antibodies and Assays Major Product Offerings
7.2.4 Abcam Neuroscience Antibodies and Assays Revenue in Global (2016-2021)
7.2.5 Abcam Key News
7.3 Bio-Rad
7.3.1 Bio-Rad Corporate Summary
7.3.2 Bio-Rad Business Overview
7.3.3 Bio-Rad Neuroscience Antibodies and Assays Major Product Offerings
7.3.4 Bio-Rad Neuroscience Antibodies and Assays Revenue in Global (2016-2021)
7.3.5 Bio-Rad Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Neuroscience Antibodies and Assays Major Product Offerings
7.4.4 Merck Neuroscience Antibodies and Assays Revenue in Global (2016-2021)
7.4.5 Merck Key News
7.5 Cell Signaling Technology
7.5.1 Cell Signaling Technology Corporate Summary
7.5.2 Cell Signaling Technology Business Overview
7.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Major Product Offerings
7.5.4 Cell Signaling Technology Neuroscience Antibodies and Assays Revenue in Global (2016-2021)
7.5.5 Cell Signaling Technology Key News
7.6 Genscript
7.6.1 Genscript Corporate Summary
7.6.2 Genscript Business Overview
7.6.3 Genscript Neuroscience Antibodies and Assays Major Product Offerings
7.6.4 Genscript Neuroscience Antibodies and Assays Revenue in Global (2016-2021)
7.6.5 Genscript Key News
7.7 Rockland Immunochemicals
7.7.1 Rockland Immunochemicals Corporate Summary
7.7.2 Rockland Immunochemicals Business Overview
7.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Major Product Offerings
7.4.4 Rockland Immunochemicals Neuroscience Antibodies and Assays Revenue in Global (2016-2021)
7.7.5 Rockland Immunochemicals Key News
7.8 BioLegend
7.8.1 BioLegend Corporate Summary
7.8.2 BioLegend Business Overview
7.8.3 BioLegend Neuroscience Antibodies and Assays Major Product Offerings
7.8.4 BioLegend Neuroscience Antibodies and Assays Revenue in Global (2016-2021)
7.8.5 BioLegend Key News
7.9 Santa Cruz Biotechnology
7.9.1 Santa Cruz Biotechnology Corporate Summary
7.9.2 Santa Cruz Biotechnology Business Overview
7.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Major Product Offerings
7.9.4 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Revenue in Global (2016-2021)
7.9.5 Santa Cruz Biotechnology Key News
7.10 Roche
7.10.1 Roche Corporate Summary
7.10.2 Roche Business Overview
7.10.3 Roche Neuroscience Antibodies and Assays Major Product Offerings
7.10.4 Roche Neuroscience Antibodies and Assays Revenue in Global (2016-2021)
7.10.5 Roche Key News
7.11 Siemens
7.11.1 Siemens Corporate Summary
7.11.2 Siemens Business Overview
7.11.3 Siemens Neuroscience Antibodies and Assays Major Product Offerings
7.11.4 Siemens Neuroscience Antibodies and Assays Revenue in Global (2016-2021)
7.11.5 Siemens Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Neuroscience Antibodies and Assays Market Opportunities & Trends in Global Market
Table 2. Neuroscience Antibodies and Assays Market Drivers in Global Market
Table 3. Neuroscience Antibodies and Assays Market Restraints in Global Market
Table 4. Key Players of Neuroscience Antibodies and Assays in Global Market
Table 5. Top Neuroscience Antibodies and Assays Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Neuroscience Antibodies and Assays Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Neuroscience Antibodies and Assays Revenue Share by Companies, 2016-2021
Table 8. Global Companies Neuroscience Antibodies and Assays Product Type
Table 9. List of Global Tier 1 Neuroscience Antibodies and Assays Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuroscience Antibodies and Assays Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type